Benzylserine and benzylcysteine are competitive inhibitors of ASCT2 [21] and have been reported to suppress cancer cell growth (benzylserine in breast cancer cells and benzylcysteine in gastric cancer cells, respectively) [22,23]. Here, SLC1A5 is linked to gastric cancer.